Understanding and manipulating immune responses is critical for successful tissue regeneration. Immunotherapy & immune engineering explores how engineered immune cells and modulatory agents enhance tissue repair, prevent graft rejection, and support integration of bioengineered constructs. Researchers are developing immune-compatible scaffolds and combining stem cell technologies with immune checkpoint modulation to achieve lasting outcomes. Engineered T cells, regulatory macrophages, and cytokine delivery systems are now being applied to modulate inflammation and direct healing. The integration of immune engineering with regenerative platforms also contributes to resolving chronic inflammation and improving scaffold longevity. Immunotherapy & immune engineering continues to evolve into a cornerstone of precision regeneration, offering targeted solutions for both autoimmune and degenerative conditions.
Title : The era of artificial intelligence (AI) and its use in regenerative medicine
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : The role of gingival fibroblasts in periodontal diseases and regeneration
Katarzyna Gawron, Medical University of Silesia in Katowice, Poland
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Role of textile materials in tissue engineering and regenerative medicine
Gokarneshan Narayanan, SSM College of Engineering (Formerly), India
Title : Induction of neo angiogenesis: A way forward for reversing necrosis in complex wounds in orthopaedic practice
Sandeep Shrivastava, Datta Meghe Institute of Medical Sciences, India
Title : Silk-derived sericin at the interface of atopic dermatitis and wound healing: Modulation of inflammation and epidermal repair
Marek Konop, Medical University of Warsaw, Poland